Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
147M
-
Number of holders
-
1140
-
Total 13F shares, excl. options
-
177M
-
Shares change
-
-945K
-
Total reported value, excl. options
-
$62.6B
-
Value change
-
-$269M
-
Put/Call ratio
-
1.59
-
Number of buys
-
474
-
Number of sells
-
-541
-
Price
-
$353.31
Significant Holders of BIOGEN INC. - COM (BIIB) as of Q3 2018
1,280 filings reported holding BIIB - BIOGEN INC. - COM as of Q3 2018.
BIOGEN INC. - COM (BIIB) has 1,140 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 177M shares
.
Largest 10 shareholders include BlackRock Inc. (16.5M shares), PRIMECAP MANAGEMENT CO/CA/ (14.9M shares), Vanguard Group Inc (14.8M shares), Clearbridge Investments, LLC (8.85M shares), STATE STREET CORP (8.84M shares), WELLINGTON MANAGEMENT GROUP LLP (5.53M shares), FMR LLC (4.32M shares), Invesco Ltd. (3.61M shares), ALLIANCEBERNSTEIN L.P. (3.12M shares), and AQR CAPITAL MANAGEMENT LLC (3.02M shares).
This table shows the top 1140 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.